Clinical Trial Update: MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MN-001 in patients with non-alcoholic fatty liver disease and comorbid type 2 diabetes mellitus and hypertriglyceridemia is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• MN-001

Snippet

Sponsor: MediciNova | Conditions: Diabetes Mellitus, Type 2, Hypertriglyceridemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING